Please check box to confirm your age.
By checking this box I confirm that I am at least 21 years old or older and of legal age to buy tobacco products in my jurisdiction. All orders are age verified through our third party system at checkout, as is required by law.
Please check box to confirm.
By checking this box I confirm that I use these products at my own risk.
Due to state legislation we are not currently shipping any products to the following states: NY and UT.
Go to Cart
Free Shipping on Qualifying $100+ USA Orders.

Carcinogen Levels In Smokers Dramatically Decreases After Switching To Vaping

Carcinogen Levels In Smokers Dramatically Decreases After Switching To Vaping


Carcinogen Levels In Smokers Dramatically Decreases After Switching To Vaping

While the vapor industry continues to grow in the U.S. and international markets, seemingly more evidence emerges every day confirming what we vapers already suspect: vaping is a much better alternative for smokers who are addicted to combustible cigarettes. The latest study, published by Oxford Academic found that someone's carcinogen intake was reduced by 57 percent after one week vaping instead of smoking cigarettes, and levels were further reduced by a whopping 64 percent after two weeks.

This is good news for vapers that believe in the power of harm reduction. Dangerous levels of cancer-causing carcinogens are found in cigarette smoke, a fact that's long been noted by the American Cancer Society as a leading cause of cancer due to cellular-level DNA changes. Some carcinogens don't affect DNA directly but can still lead to cancer in other ways. For example, they may cause cells to divide at a faster than normal rate, which could increase the chances that DNA changes will occur.

Vapor products have been falsely linked to producing carcinogens, largely due to faulty testing techniques. But researchers and scientists (mostly in studies outside of the United States) have found that the carcinogen level of nicotine (the common link between vapor products and tobacco) makes up a fraction of the carcinogen levels in cigarettes, with a host of other toxic compounds producing most of the carcinogens in cigarettes.


One of the interesting facts about the study was that, unlike most research into the benefits of quitting smoking by way of vaping, this research was conducted in the United States. Testing was led by Dr. Maciej Goniewicz of the Roswell Park Comprehensive Cancer Center in Buffalo, New York. The fact that the Goniewicz study is based in America may be crucial in gaining acceptance from U.S. public health agencies including the federal Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC).

Research started with 20 different smokers who agreed to quit cigarettes and take up vaping for two weeks. The scientists measured for 17 major carcinogens associated with combustible cigarette smoke, 13 carcinogens related to tobacco cigarette ingredients, 7 different metabolites, 4 polycyclic aromatic hydrocarbons (fluorene, naphthalene, phenanthrene, pyrene), and 8 volatile organic compounds (VOCs).

Researchers determined that switching to vaping for just two weeks significantly decreased carcinogenic intake for smokers, and estimated that making the switch resulted in a 61 percent chance that the smoker can quit permanently. Throughout the study, about 45 percent of the participants were able to quit altogether for two weeks, though just over half the participants found themselves smoking at least part-time before the two weeks were up.


There are a number of problems with this study, one of which is the small control group from which these conclusions were drawn. However, it represents a significant step forward for the United States, which has been overly reluctant to acknowledge any potential benefit from vaping.

Here in the vaping community, we’ll continue to monitor the ongoing research into potential health benefits for smokers who deal with toxic carcinogens and the harmful effects associated with them.